# Bright Minds (DRUG) — Analyst Forecast

DRUG · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/drug/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 8 | 0 | 0 | 8 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $145.00 | $147.33 | $150.00 | 3 |

Last price $54.21 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 15, 2026 | Wolfe Research | Initiated Coverage | Outperform | $150.00 |
| Aug 19, 2026 | HC Wainwright & Co. | Maintained | Buy | $145.00 |
| Aug 17, 2026 | BTIG | Maintained | Buy | $147.00 |
| Jun 1, 2026 | HC Wainwright & Co. | Maintained | Buy | $145.00 |
| May 20, 2026 | Piper Sandler | Maintained | Overweight | $220.00 |
| Apr 13, 2026 | Jefferies | Initiated Coverage | Buy | $145.00 |
| Mar 30, 2026 | BTIG | Maintained | Buy | $147.00 |
| Mar 4, 2026 | HC Wainwright & Co. | Maintained | Buy | $145.00 |
| Feb 17, 2026 | BTIG | Maintained | Buy | $147.00 |
| Jan 7, 2026 | BTIG | Maintained | Buy | $147.00 |
| Jan 6, 2026 | BTIG | Maintained | Buy | $147.00 |
| Jan 2, 2026 | Chardan Capital | Maintained | Buy | $80.00 |
| Dec 30, 2025 | HC Wainwright & Co. | Maintained | Buy | $115.00 |
| Sep 15, 2025 | HC Wainwright & Co. | Maintained | Buy | $85.00 |
| Sep 8, 2025 | BTIG | Initiated Coverage | Buy | $72.00 |
| Aug 19, 2025 | HC Wainwright & Co. | Maintained | Buy | $85.00 |
| Jul 2, 2025 | Cantor Fitzgerald | Initiated Coverage | Overweight | — |
| May 21, 2025 | Chardan Capital | Maintained | Buy | $80.00 |
| May 13, 2025 | TD Cowen | Initiated Coverage | Buy | — |
| May 7, 2025 | Chardan Capital | Initiated Coverage | Buy | $80.00 |

## Frequently Asked Questions

### What is the price target for DRUG stock?

The average 12-month analyst price target for Bright Minds (DRUG) is $147.33, with a high estimate of $150.00 and a low of $145.00, across 3 analysts.

### Is DRUG a buy, sell, or hold?

Analysts covering Bright Minds currently average a Buy rating: 8 buy, 0 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for DRUG?

The average price target of $147.33 implies 171.78% upside from the last price of $54.21.

### What is the latest analyst rating on DRUG?

On Oct 15, 2026, Wolfe Research initiated coverage of Bright Minds at Outperform with a price target of $150.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).